A new report has been published by Stratview Research, titled, “Proton Pump Inhibitors (PPIs) Market” The experts authoring this report have made an effort at providing in-depth information on leading growth drivers, restrictions, challenges, current and upcoming trends, and opportunities to offer a comprehensive assessment of the global Proton Pump Inhibitors (PPIs) Market. Users can use the analysis included in this report to plan effective growth strategies and prepare for future challenges beforehand.
Market segmentation
Market segmentation has been done correctly to help the users define and better understand their target audiences and ideal customers. Market segmentation in this report allows you to identify the right market for your products and then target your marketing more effectively.
Drug Type Trends
Based on drug type, the global proton pump inhibitors market has been bifurcated into over-the-counter drugs and prescription drugs.
- The over-the-counter drugs segment is further categorized into omeprazole, lansoprazole, esomeprazole, and others.
- Among these, the esomeprazole under the OTC drug segment garnered the highest market share in 2020 and is likely to grow at a healthy CAGR during the forecast timeline.
- Esomeprazole is mainly indicated to treat the symptoms of heartburn, Gastroesophageal Reflux Disease (GERD), and other disorders such as excessive stomach acids, thus bolstering the segment growth.
Regional Trends
By region, the North American market accounted for the largest market share in 2020 and is estimated to grow at a steady CAGR during the assessment period. This can be attributed to increasing approvals of proton pump inhibitor products and the increasing prevalence of GERD in the US, Canada, and Mexico, which proliferates the industry growth in the region. Moreover, GERD affects almost 20% of adults in the US, thereby making the disease an important concern, which propels regional growth.
As the novel coronavirus (COVID-19) crisis takes over the world, our team of market analysts is continuously tracking the changes in the markets, as well as the industry behaviours of the consumers globally and their estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.
Competitive landscape
Relying on data to make business decisions and to have a competitive advantage, is a critical aspect every key player needs to be familiar with. The report throws light on the competitive scenario of the global Proton Pump Inhibitors (PPIs) Market along with a list of Key players.
Here are few –
- AstraZeneca PLC/AB (UK),
- Bayer AG (Germany),
- Pfizer Inc. (The U.S),
- Cadila Pharmaceuticals Limited (India),
- Eisai Pharmaceuticals India Pvt. Ltd (India),
- Santarus, Inc. (The U.S),
- Wyeth, LLC (The U.S),
- Janssen Pharmaceutical (Belgium),
- Takeda Pharmaceutical Company Limited (Japan), and
- Sanofi S.A. (France).
Report Features –
This market report includes the following features –
Custom Research:
Stratview research offers custom research services across the sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to sales@stratviewresearch.com
About Stratview Research –
Stratview Research is a leading market research firm that offers wide range of services like syndicated market reports, consulting, sourcing intelligence, and customer research, etc. Stratview Research’s offerings include comprehensive market intelligence in the form of research reports, and consulting services. Our team which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 500 companies.